PBM Price Transparency and Accountability Act

# PBM Price Transparency and Accountability Act (S 3345) **What It Would Do** This bill aims to increase transparency and accountability for Pharmacy Benefit Managers (PBMs)—companies that act as middlemen between health insurance plans, pharmacies, and drug manufacturers. The legislation would require PBMs to disclose more information about how they negotiate drug prices, which drugs they prefer over others, and how much money they keep versus pass along to pharmacies and insurers. The goal is to shed light on pricing practices that are often kept secret from consumers and even from the healthcare providers involved. **Who It Affects** This bill would impact PBMs, health insurance companies, pharmacies, patients filling prescriptions, and drug manufacturers.

Patients may be affected because clearer pricing information could potentially lead to lower out-of-pocket drug costs, though the direct effects would depend on implementation. Pharmacies could gain transparency about how they're reimbursed, and insurers could better understand what they're paying PBMs. **Current Status** As of now, the bill (S 3345) is in committee, meaning it's being reviewed but has not yet been voted on by the full Senate. It was introduced in the 119th Congress by Senator Mike Crapo (R-ID).